Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 2/20 | 0.51 |
| ▸ | KDR | P35968 | 8/20 | 0.47 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.47 |
| ▸ | JAK2 | O60674 | 2/20 | 0.47 |
| ▸ | RET | P07949 | 2/20 | 0.47 |
| ▸ | GSK3A | P49840 | 2/20 | 0.47 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.47 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.47 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.47 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.47 |
| ▸ | DYRK1B | Q9Y463 | 2/20 | 0.47 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.47 |
| ▸ | PRKACA | P17612 | 2/20 | 0.47 |
| ▸ | CDK8 | P49336 | 2/20 | 0.47 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.47 |
| ▸ | AURKA | O14965 | 1/20 | 0.47 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.47 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.47 |
| ▸ | CSF1R | P07333 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL32685346 | 0.98 | DYRK1A (0.50) | DYRK1AKDRCLK4JAK2RET | |
| SCHEMBL21412044 | 0.81 | DYRK1A (0.54) | DYRK1AKDRCLK4JAK2RET | |
| Hydrochloric Acid SCHEMBL21411934 | 0.79 | DYRK1A (0.53) | DYRK1AKDRCLK4JAK2RET | |
| SCHEMBL360789 | 0.73 | DYRK1A (0.77) | DYRK1AKDRCLK4JAK2RET | |
| SCHEMBL3514678 | 0.72 | DYRK1A (0.70) | DYRK1AKDRCLK4JAK2RET | |
| SCHEMBL21076234 | 0.72 | DYRK1A (0.60) | DYRK1AKDRCLK4JAK2RET | |
| SCHEMBL15637559 | 0.72 | DYRK1A (0.51) | DYRK1AKDRCLK4JAK2RET | |
| SCHEMBL32685354 | 0.72 | TGFBR1 (0.41) | DYRK1ARETKDM4EALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL21411936 | 0.71 | DYRK1A (0.68) | DYRK1AKDRCLK4JAK2RET | |
| SCHEMBL15640019 | 0.71 | TGFBR1 (0.44) | DYRK1AKDRCLK4JAK2RET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577226-B2 | Compounds for treating Huntington's disease | PTC THERAPEUTICS, INC. (US) | 2026-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577226-B2 | Compounds for treating Huntington's disease | HTT, HYPK, GRIN2C | DYRK1A 3483/4885KDR 3372/4885CLK4 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.